Rebecca A. Taub
Founder, Senior Scientific & Medical Advisor and DirectorDr. Rebecca A. Taub, also known as Becky, M.D., Founded Madrigal Pharmaceuticals, Inc. in September 2011 and has been its Director since July 2016, was its President of Research & Development since June 2019 until April 21, 2025 and served as its Chief Medical Officer from July 2016 until April 21, 2025. Dr. Taub serves as Senior Scientific & Medical Advisor at Madrigal Pharmaceuticals, Inc. since April 21, 2025. Dr. Taub served as Executive Vice President, Research & Development of Madrigal Pharmaceuticals, Inc. since July 2016 until July 11, 2019. Dr. Taub serves as an Independent Director of BriaCell Therapeutics Corp. since March 7, 2019. Dr. Taub served on the Board of Directors of Private Madrigal and as Chief Executive Officer of Private Madrigal from its inception in September 2011 through the Merger in July 2016. Prior to joining Private Madrigal, Dr. Taub served as Senior Vice President, Research and Development of VIA Pharmaceuticals from 2008 to 2011 and as Vice President, Research, Metabolic Diseases at Hoffmann-La Roche from 2004 to 2008. In those positions, Dr. Taub oversaw clinical development and drug discovery programs in cardiovascular and metabolic diseases including the conduct of a series of Phase I and II proof of conduct clinical trials. Dr. Taub led drug discovery including target identification, lead optimization and advancement of preclinical candidates into clinical development. From 2000 through 2003, Dr. Taub worked at Bristol-Myers Squibb Co. and DuPont Pharmaceutical Company, in a variety of positions, including Executive Director of CNS and metabolic diseases research. Before becoming a pharmaceutical executive, Dr. Taub was a tenured Howard of Genetics and Medicine at the University of Pennsylvania and remains an adjunct professor. Dr. Taub is the author of more than 120 research articles. Before joining the faculty of the University of Pennsylvania, Dr. Taub served as an Assistant Professor at the Joslin Diabetes Center of Harvard Medical School, Harvard University and an associate investigator with the Howard Hughes Medical Institute. She has authored more than 120 research articles. Dr. Taub received her M.D. from Yale University School of Medicine and B.A. from Yale College. Dr. Taub completed her Residency at Yale-New Haven Hospital and her Post-Doctoral Fellowship at Harvard Medical School.
Positions
- Company NameMadrigal Pharmaceuticals, Inc.Stock CodeMDGLPositionFounder, Senior Scientific & Medical Advisor and DirectorColleagues
- WJWilliam J. SiboldCEO, President & Director
- JCJulian Charles BakerIndependent Chairman of the Board
- MCMardi C. DierExecutive VP & CFO
- SKShannon KelleyExecutive VP, Chief Legal Officer & Corporate Secretary
- CHCarole HuntsmanExecutive VP & Chief Commercial Officer
- RSRichard Steven LevyIndependent Director
- DJDaniel J. BrennanIndependent Director
